FELIPE ANDREIUOLO
Graduou-se em medicina pela UFF e concluiu residência médica em Patologia no INCa. Tem mestrado em neuropatologia pela UFRJ e tese de doutorado em patologia molecular de tumores cerebrais pediátricos pela Universidade Paris XI. Radicou-se por 14 anos na Europa, onde trabalhou como neuropatologista no Hospital Ste. Anne (Paris) e no centro Nacional para o Diagnóstico de tumores cerebrais na Universidade de Bonn (Alemanha). Atualmente atua como neuropatologista na Rede D’Or/IDOR e no Instituto Estadual do Cérebro Paulo Niemeyer.
Confira a agenda de atividades
22 DE MARÇO | SEXTA-FEIRA
• Room 3
08:15-10:30
SESSION 1: PEDIATRIC POSTERIOR FOSSA TUMORS
Pediatric posterior fossa tumors: wich is the role of the radiologist?
Integrating IH up to methylation in the WHO Classification for diagnosis of posterior fossa tumors in children and adolescents.What does the neuro-oncologist need to know?
How to avoid complications in posterior fossa surgery for pediatric patients?
Safeness and complications of radiotherapy for pediatric posterior fossa patients
The Brazilian Medulloblastoma Protocol for children and adolescents > 4 years old
Unresectable Low-grade glioma: Chemotherapy x Target therapy, what is the best treatment at diagnosis?
Discussion
Moderator: Nasjla Saba da Silva (SP)
Moderator: Enrico Ghizoni (SP)
Pediatric posterior fossa tumors: wich is the role of the radiologist?
Speaker: Celso Hygino (RJ)
Integrating IH up to methylation in the WHO Classification for diagnosis of posterior fossa tumors in children and adolescents.What does the neuro-oncologist need to know?
Speaker: Felipe Andreiuolo (RJ)
How to avoid complications in posterior fossa surgery for pediatric patients?
Speaker: Jorge Bizzi (RS)
Safeness and complications of radiotherapy for pediatric posterior fossa patients
Speaker: Michael Jenwei Chen (SP)
The Brazilian Medulloblastoma Protocol for children and adolescents > 4 years old
Speaker: Sidnei Epelman (SP)
Unresectable Low-grade glioma: Chemotherapy x Target therapy, what is the best treatment at diagnosis?
Speaker: Jason Fangusaro (Estados Unidos)
Discussion
23 DE MARÇO | SÁBADO
• Room 2
08:15-10:30
SESSION 3: SKULL BASE TUMORS
Update on the genetics of pituitary adenomas and a glimpse of the future
Multimodal non-surgical treatments of aggressive pituitary tumors
Advancements in pituary surgery for optimal outcomes
Surgical frontiers: advancements in treating craniopharyngiomas
Confronting recurrence: latest insights in treatment of craniopharyngiomas
Vestibular schwannomas: effectiveness and complications of SRS
Vestibular schwannomas: effectiveness and complications of mircosurgery
Discussion
Moderator: Mateus Reghin Neto (SP)
Moderator: Allan Dias Polverini (SP)
Moderator: Eduardo Weltman (SP)
Moderator: Mateus Dal Fabbro (SP)
Update on the genetics of pituitary adenomas and a glimpse of the future
Speaker: Felipe Andreiuolo (RJ)
Multimodal non-surgical treatments of aggressive pituitary tumors
Speaker: Andrea Glezer (SP)
Advancements in pituary surgery for optimal outcomes
Speaker: João Paulo Almeida (Estados Unidos)
Surgical frontiers: advancements in treating craniopharyngiomas
Speaker: João Paulo Almeida (Estados Unidos)
Confronting recurrence: latest insights in treatment of craniopharyngiomas
Speaker: Caroline Chaul (SP)
Vestibular schwannomas: effectiveness and complications of SRS
Speaker: Antonio de Salles (SP)
Vestibular schwannomas: effectiveness and complications of mircosurgery
Speaker: Ricardo Ramina (PR)
Discussion
Realização
Organização
agência de turismo
PATROCÍNIO PRATA
PATROCÍNIO BRONZE
APOIO
Apoio Institucional
